Clinical Trials

Breast Neoplasms, Neoplasm, Residual, Breast Neoplasms, Male

NCT05708235 2026-03-05

MiRaDoR

976 enrolled

Breast Neoplasms, Neoplasm, Residual

NCT07069595 2026-03-05

PREDICT-RD

78 enrolled

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT07211178 2026-03-04

GEMINI Breast

900 enrolled

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT07025785 2026-01-15

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

Phase NA Recruiting

100 enrolled

Breast Neoplasms, Lymphatic Metastasis, Neoplasm, Residual

NCT06663787 2025-11-28

HER2 CR

Active not recruiting

50 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

NCT05232916 2025-10-03

FLAMINGO-01

Phase 3 Recruiting

750 enrolled

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm, Residual

NCT03945721 2025-09-29

UNITY

21 enrolled

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT04434040 2025-08-19

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

40 enrolled

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT05196087 2025-07-02

NIP IT!

BreastDermatologicEndocrineGastrointestinalNET

500 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Breast Neoplasms, Melanoma, Neoplasm, Residual

NCT04674306 2025-05-23

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

35 enrolled

Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT04768426 2025-03-20

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

40 enrolled

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT04841148 2025-03-11

PALAVY

96 enrolled

Breast Neoplasms, Neoplasm, Residual

NCT06230185 2025-01-07

B-STRONGER-I

422 enrolled

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT06595966 2024-09-19

Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery

80 enrolled

Breast Neoplasms, Neoplasm, Residual

NCT02306096 2024-02-09

SCAN-B

20,000 enrolled

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm, Residual

NCT01401959 2018-06-15

Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy

Phase 2 Completed

127 enrolled 11 charts